Medicare Enrolled

Dr. Soheil Soleymani, MD

Internal Medicine · West Hollywood, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
8797 BEVERLY BLVD STE 315, West Hollywood, CA 90048
3106590123
In practice since 2017 (8 years)
NPI: 1902329931 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Soleymani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Soleymani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Soleymani

Dr. Soheil Soleymani is an internal medicine specialist in West Hollywood, CA, with 8 years of NPI registration. Based on federal Medicare data, Dr. Soleymani performed 2,341 Medicare services across 506 unique beneficiaries.

Between the years covered by Open Payments, Dr. Soleymani received a total of $3,514 from 26 pharmaceutical and/or device companies across 114 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Soleymani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 8 years in practice ▲ Top 14% volume in CA $3,514 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,341
Medicare services
Top 14% in CA for internal medicine
506
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~293 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
1,915 $67 $498
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
185 $146 $998
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
63 $100 $742
Nursing facility visit, moderate complexity
A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes.
62 $91 $290
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
53 $78 $250
Transitional care management, high complexity
Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem.
36 $243 $770
Initial nursing facility care, moderate complexity
Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes.
27 $113 $360
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,514
Total received (2019-2024)
Avg $703/year across 5 years
Top 19% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
114
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,295 (65.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,219 (34.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$237
2023
$701
2022
$766
2021
$1,742
2019
$67

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$113
Novartis Pharmaceuticals Corporation
$48
Lilly USA, LLC
$23
PFIZER INC.
$20
GlaxoSmithKline, LLC.
$19
Almatica Pharma LLC
$15
Top 3 companies account for 77.5% of 2024 payments
All-time payments by company (2019-2024) ›
Biohaven Pharmaceuticals, Inc.
$1,219
Amgen Inc.
$463
AbbVie Inc.
$270
ABBVIE INC.
$267
Amarin Pharma Inc.
$177
Novartis Pharmaceuticals Corporation
$145
Lilly USA, LLC
$145
PFIZER INC.
$105
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$93
Boehringer Ingelheim Pharmaceuticals, Inc.
$76
Biohaven Pharmaceutical Holding Company Ltd.
$70
Bayer Healthcare Pharmaceuticals Inc.
$67
Almatica Pharma LLC
$47
Novo Nordisk Inc
$45
Merck Sharp & Dohme Corporation
$43
Bausch Health US, LLC
$37
IBSA Pharma Inc.
$37
ARBOR PHARMACEUTICALS, INC.
$36
Lundbeck LLC
$31
Abbott Laboratories
$25
Bayer HealthCare Pharmaceuticals Inc.
$22
Takeda Pharmaceuticals U.S.A., Inc.
$22
Astellas Pharma US Inc
$20
GlaxoSmithKline, LLC.
$19
Kowa Pharmaceuticals America, Inc.
$18
AstraZeneca Pharmaceuticals LP
$15
Top 3 companies account for 55.5% of all-time payments
Associated products mentioned in payments ›
APLENZIN · Aimovig · BELSOMRA · COMIRNATY · CREON · EMGALITY · ENTRESTO · EVENITY · Edarbi · FARXIGA · GRALISE · INFINITY · JARDIANCE · Kerendia · LEQVIO · LINZESS · LOREEV XR · Licart · MOUNJARO · MYRBETRIQ · NURTEC ODT · Otezla · PREVNAR 20 · QULIPTA · SEGLENTIS · Saxenda · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tirosint · UBRELVY · VRAYLAR · VYEPTI · Vascepa · WELLBUTRIN · Wegovy · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (65%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an internal medicine specialist in West Hollywood?
Compare internal medicine physicians in the West Hollywood area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
4,889
Per 100K population
49.6
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Soleymani is a mixed practice specialist, with above-average Medicare volume (top 14% in CA), with low-engagement industry engagement in the top 19% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Soleymani experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Soleymani performed 1,915 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Soleymani receive payments from pharmaceutical companies?
Yes. Dr. Soleymani received a total of $3,514 from 26 companies across 114 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Soleymani's costs compare to other internal medicine physicians in West Hollywood?
Dr. Soleymani's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Soleymani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →